Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.
AirSculpt Technologies Inc. (AIRS) delivers innovative body contouring solutions through its patented AirSculpt® technology, combining medical precision with minimally invasive techniques. This news hub provides investors and industry observers with essential updates on corporate developments, clinical advancements, and market positioning.
Access official press releases covering earnings reports, facility expansions, technology patents, and partnership announcements. Our curated collection enables efficient tracking of operational milestones in the competitive medical aesthetics sector.
Key coverage areas include regulatory filings, procedure innovation updates, executive leadership changes, and strategic growth initiatives. All content is sourced directly from company communications to ensure accuracy and timeliness.
Bookmark this page for streamlined monitoring of AIRS's progress in advancing body contouring technologies and expanding its North American clinic network. Verify publication dates for the latest developments in this dynamic healthcare segment.
AirSculpt Technologies (NASDAQ: AIRS) announces the opening of its first international Elite Body Sculpture location in London, set for the first half of 2023. This expansion aims to broaden its reach and enhance its premium body contouring services. The company plans to open a total of five new locations in 2023. Dr. Aaron Rollins, CEO, expressed enthusiasm for the London location, highlighting a luxury experience for clients, and welcomed Rana Das-Gupta as the new Medical Director, emphasizing his expertise in body fat reduction.
AirSculpt Technologies (NASDAQ: AIRS) announces the opening of its first international Elite Body Sculpture center in Toronto, Canada, marking a significant milestone in its global expansion. This new location offers AirSculpt's premium, minimally invasive body contouring procedures aimed at providing comfort and precision. The founder, Dr. Aaron Rollins, emphasized the rising demand for the proprietary AirSculpt method, promising Canadians enhanced body transformation experiences. For more information about the Toronto site and services, visit www.airsculpt.ca.
AirSculpt Technologies (NASDAQ:AIRS) reported a 12.2% revenue increase to $38.9 million for Q3 2022, driven by new center openings. However, a net loss of $7.4 million was recorded, impacted by increased equity compensation and public company expenses. Year-to-date revenue rose 33.8% to $128.1 million, with a case volume growth of 19.1%. Adjusted EBITDA decreased to $9.2 million, affected by rising costs. The Company lowered its 2022 revenue outlook to $168-170 million and adjusted EBITDA forecast to $45-47 million, while planning four new center openings.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) has announced a new credit agreement with lenders, securing $85 million in term loans and a $5 million revolving loan facility. This funding will pay off an existing $83.6 million credit facility due October 28, 2023. The new agreement, maturing on November 7, 2027, is expected to save the company approximately $2 million annually in cash interest, with no prepayment penalties. CFO Dennis Dean expressed satisfaction with the refinancing, noting it provides flexibility to pursue strategic growth plans.
AirSculpt Technologies, Inc. (NASDAQ: AIRS) has announced the opening of its new centers in Philadelphia and Boston, bringing the total to 21 locations across the U.S. The company specializes in premium body contouring procedures utilizing its proprietary AirSculpt technology, known for its minimally invasive approach that facilitates faster healing and more precise results. Over 30,000 procedures have been conducted nationally, indicating a robust demand for their services. The Boston center opened in July, while the Philadelphia center is centrally located near King of Prussia Mall.
AirSculpt Technologies (NASDAQ: AIRS) has announced that it will release its third quarter results on November 10, 2022, after market close. Following this, a conference call will be held on November 11, 2022, at 8:30 AM ET for investors and the public to discuss the results. Access to the call is available via phone or through a webcast on the company's investor relations website. AirSculpt is known for its proprietary AirSculpt® method, which offers a minimally invasive body contouring procedure aiming to deliver significant results for patients.
AirSculpt Technologies (NASDAQ: AIRS) announced management's participation at the Piper Sandler Growth Frontiers Conference in Nashville, TN on September 13, 2022. The event will include 1x1 investor meetings and a fireside chat at 5:00 PM ET. A live webcast and replay will be accessible on AirSculpt's investor relations site.
AirSculpt specializes in premium body contouring procedures, using its proprietary AirSculpt® method for minimally invasive fat removal, aiming to deliver exceptional results for patients.
AirSculpt Technologies (NASDAQ: AIRS) has introduced AirSculpt Smooth, a new cellulite removal procedure that is FDA-cleared and minimally invasive. This one-time procedure offers complete removal of stubborn cellulite dimples and is designed to be performed alongside AirSculpt's fat removal method. Clients can expect to resume normal activities within 24-48 hours. The procedure utilizes the Aveli device from Revelle Aesthetics and aims to provide lasting results that improve over three months, enhancing the body contouring experience.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a strong second quarter for 2022, with a 42% year-over-year revenue increase to $49.7 million. The company declared a $0.41 per share special cash dividend, payable on September 14, 2022. Despite revenue growth, net income fell to $0.6 million, impacted by rising equity-based compensation and public company costs. Year-to-date results show a 46% revenue increase to $89.2 million. The company maintains a revenue outlook of $175-$179 million for 2022 and aims to open four new centers annually.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced a special cash dividend of $0.41 per share to be paid on September 14, 2022, for shareholders on record as of August 26, 2022. This decision reflects the Board of Directors' confidence in the company's long-term growth potential and strong financial position, as stated by Chairman Adam Feinstein. The dividend will be funded by excess cash from operations, while ensuring continued financial flexibility for future business growth.